Boston Therapeutics to Present Findings of BTI-320 as Therapy for Glycemic Control at 50th Annual Meeting of European Association for the Study of Diabetes
16 sept. 2014 07h20 HE
|
Boston Therapeutics
MANCHESTER, NH--(Marketwired - Sep 16, 2014) - Boston Therapeutics, Inc. (OTCQB: BTHE) ("Boston Therapeutics" or "the Company"), a developer of complex carbohydrate therapeutics to treat diabetes...
Boston Therapeutics to Present at National Investment Banking Conference on September 16, 2014
15 sept. 2014 08h27 HE
|
Boston Therapeutics
MANCHESTER, NH--(Marketwired - Sep 15, 2014) - Boston Therapeutics, Inc. (OTCQB: BTHE), developer of complex carbohydrate therapeutics to treat diabetes, announced that David Platt, Ph.D., Chief...
Boston Therapeutics to Present at Rodman & Renshaw Annual Global Investment Conference on September 10, 2014
05 sept. 2014 08h36 HE
|
Boston Therapeutics
MANCHESTER, NH--(Marketwired - Sep 5, 2014) - Boston Therapeutics, Inc. (OTCQB: BTHE), developer of complex carbohydrate therapeutics to treat diabetes, announced that David Platt, Ph.D.,...
Boston Therapeutics Completes Enrollment of Patients With Type 2 Diabetes in Phase IIb Study on BTI-320 in the U.S.
20 août 2014 08h11 HE
|
Boston Therapeutics
MANCHESTER, NH--(Marketwired - Aug 20, 2014) - Boston Therapeutics, Inc. (OTCQB: BTHE), a developer of complex carbohydrate therapeutics to treat diabetes, has completed enrollment of its Phase IIb...
Boston Therapeutics Appoints Noted Diabetes Specialist Jaime A. Davidson, M.D. to Its Medical Advisory Board
18 août 2014 07h25 HE
|
Boston Therapeutics
MANCHESTER, NH--(Marketwired - Aug 18, 2014) - Boston Therapeutics, Inc. (OTCQB: BTHE), a developer of complex carbohydrate therapeutics to treat diabetes, has appointed noted diabetes...
Boston Therapeutics Reports Corporate Update and Financial Results for the Second Quarter Ended June 30, 2014
08 août 2014 10h55 HE
|
Boston Therapeutics
MANCHESTER, NH--(Marketwired - Aug 8, 2014) - Boston Therapeutics, Inc. (OTCQB: BTHE) ("Boston Therapeutics" or "the Company"), a leading developer of compounds that address diabetes using complex...
Boston Therapeutics Expands Medical Advisory Board
05 août 2014 07h00 HE
|
Boston Therapeutics
MANCHESTER, NH--(Marketwired - Aug 5, 2014) - Boston Therapeutics, Inc. (OTCQB: BTHE) ("Boston Therapeutics" or "the Company"), a developer of complex carbohydrate therapeutics to treat diabetes,...
Boston Therapeutics to Sponsor Symposium at American Chemical Society's Fall National Meeting in San Francisco
30 juil. 2014 06h30 HE
|
Boston Therapeutics
MANCHESTER, NH--(Marketwired - Jul 30, 2014) - Boston Therapeutics, Inc. (OTCQB: BTHE), a developer of complex carbohydrate therapeutics to treat diabetes, is sponsoring a symposium to be held at...
Boston Therapeutics Appoints Zbigniew J. Witczak, Ph.D., to Its Scientific Advisory Board
29 juil. 2014 06h30 HE
|
Boston Therapeutics
MANCHESTER, NH--(Marketwired - Jul 29, 2014) - Boston Therapeutics, Inc. (OTCQB: BTHE), a developer of complex carbohydrate therapeutics to treat diabetes and inflammatory diseases, has appointed...
Boston Therapeutics Appoints Benjamin Rivnay, Ph.D. to Chief Scientist
09 juil. 2014 07h00 HE
|
Boston Therapeutics
MANCHESTER, NH--(Marketwired - Jul 9, 2014) - Boston Therapeutics, Inc. (OTCQB: BTHE), a developer of complex carbohydrate therapeutics to treat diabetes and inflammatory diseases, has appointed...